Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants
Abstract
Aerosolized immunoglobulin in the dosage used had no substantial beneficial effect on RSV bronchiolitis. Despite these findings passive immunotherapy for treatment of RSV-induced lower respiratory tract infection deserves further evaluation before being discarded as ineffective.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Infant
newborn
Clinical Trial
Randomized Controlled Trial
Antibodies
Multicenter Study
Antigens
Viral / analysis
respiratory syncytial virus infections / immunology
respiratory syncytial viruses / isolation & purification
aerosols
respiratory syncytial virus infections / drug therapy*
respiratory syncytial viruses / immunology
p c rimensberger
u b schaad
pmid:8852908
doi:10.1097/00006454-199603000-00007
a burek-kozlowska
viral / pharmacology*
chlorocebus aethiops
immunoglobulins / pharmacology*
respiratory syncytial virus infections / virology
respiratory syncytial viruses / classification
respiratory syncytial viruses / drug effects*
vero cells
Access
Citation
ID:
112207
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112207
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet